Please assess the completion status of the following clinical trial:

Trial Title: Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women aged ≥ 18 years~* Currently undergoing an IVF or ICSI cycle or are oocyte-donors~* Have completed controlled ovarian stimulation~* Have received at least 5 doses of Bemfola®~* Are pituitary suppressed with a GnRH antagonist~* Have undergone oocyte retrieval~* Have signed the Informed Consent Form~Exclusion Criteria:~* Hypersensitivity to the active substance follitropin alfa, FSH or to any of the excipients listed~* Presence of tumours of the hypothalamus or pituitary gland

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).